| Proto-oncogene structure and breast cancer prognosis |
| MV Viola |
|
JCO Jul 1 1987: 993–995.
[PDF]
|
 |
| Blood levels of chemotherapeutic agents and clinical outcome |
| JR Bertino |
|
JCO Jul 1 1987: 996.
[PDF]
|
|
| "High-risk" acute lymphocytic leukemia |
| AI Freeman |
|
JCO Jul 1 1987: 997–998.
[PDF]
|
|
|
Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease |
| |
MJ Cline, H Battifora, and J Yokota |
| |
JCO Jul 1 1987: 999–1006.
[Abstract]
[PDF]
|
|
|
Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial |
| |
JH Rodman, M Abromowitch, JA Sinkule, FA Hayes, GK Rivera, and WE Evans |
| |
JCO Jul 1 1987: 1007–1014.
[Abstract]
[PDF]
|
|
|
Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L |
| |
GV Dahl, GK Rivera, AT Look, HO Hustu, DK Kalwinsky, M Abromowitch, J Mirro, J Ochs, SB Murphy, and RK Dodge |
| |
JCO Jul 1 1987: 1015–1021.
[Abstract]
[PDF]
|
|
|
Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study |
| |
N Hakami, AT Look, PC Steuber, J Krischer, R Castleberry, R Harris, Y Ravindranath, and TJ Vietti |
| |
JCO Jul 1 1987: 1022–1025.
[Abstract]
[PDF]
|
|
|
Prognostic factors in childhood acute myelogenous leukemia |
| |
HE Grier, RD Gelber, BM Camitta, MJ Delorey, MP Link, KN Price, PR Leavitt, and HJ Weinstein |
| |
JCO Jul 1 1987: 1026–1032.
[Abstract]
[PDF]
|
|
|
Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation |
| |
P McGlave, D Arthur, R Haake, D Hurd, W Miller, G Vercellotti, D Weisdorf, T Kim, N Ramsay, and J Kersey |
| |
JCO Jul 1 1987: 1033–1040.
[Abstract]
[PDF]
|
|
|
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy |
| |
MJ Crnkovich, K Leopold, RT Hoppe, and PM Mauch |
| |
JCO Jul 1 1987: 1041–1049.
[Abstract]
[PDF]
|
|
|
Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients |
| |
MH Leibenhaut, RT Hoppe, A Varghese, and SA Rosenberg |
| |
JCO Jul 1 1987: 1050–1055.
[Abstract]
[PDF]
|
|
|
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast |
| |
RC Leonard, MA Cornbleet, SB Kaye, M Soukop, G White, AW Hutcheon, S Robinson, ME Kerr, and JF Smyth |
| |
JCO Jul 1 1987: 1056–1063.
[Abstract]
[PDF]
|
|
|
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy |
| |
R Motzer, G Bosl, R Heelan, W Fair, W Whitmore, P Sogani, H Herr, and M Morse |
| |
JCO Jul 1 1987: 1064–1070.
[Abstract]
[PDF]
|
|
|
The treatment of advanced metastatic seminoma: experience in 55 cases |
| |
SD Fossa, L Borge, N Aass, NB Johannessen, AE Stenwig, and O Kaalhus |
| |
JCO Jul 1 1987: 1071–1077.
[Abstract]
[PDF]
|
|
|
Phase II studies of single-agent cimetidine and the combination N- phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma |
| |
RF Morton, ET Creagan, SA Cullinan, JA Mailliard, L Ebbert, MH Veeder, and M Chang |
| |
JCO Jul 1 1987: 1078–1082.
[Abstract]
[PDF]
|
|
|
Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma |
| |
AC Buzaid, A Robertone, C Kisala, and SE Salmon |
| |
JCO Jul 1 1987: 1083–1089.
[Abstract]
[PDF]
|
|
|
Elevation of cerebrospinal fluid catecholamine metabolites in patients with intracranial tumors of neuroectodermal origin |
| |
B Bostrom and BL Mirkin |
| |
JCO Jul 1 1987: 1090–1097.
[Abstract]
[PDF]
|
|
|
Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents |
| |
EE Reynoso, FA Shepherd, HA Messner, HA Farquharson, MB Garvey, and MA Baker |
| |
JCO Jul 1 1987: 1098–1106.
[Abstract]
[PDF]
|
|
|
Cerebellar metastases: diagnostic and management considerations |
| |
C Fadul, KE Misulis, and RG Wiley |
| |
JCO Jul 1 1987: 1107–1115.
[Abstract]
[PDF]
|
|
|
Etiology and treatment of chemotherapeutic agent extravasation injuries: a review |
| |
R Rudolph and DL Larson |
| |
JCO Jul 1 1987: 1116–1126.
[Abstract]
[PDF]
|
|
| Screening for recurrent breast cancer |
| GE Umbach |
|
JCO Jul 1 1987: 1127a.
[PDF]
|
|
| The other CHOP |
|
|
JCO Jul 1 1987: 1127b–1129.
[PDF]
|
|
| Low-dose cytosine arabinoside in adult chronic myelomonocytic leukemia |
| P Fenaux, JP Jouet, and F Bauters |
|
JCO Jul 1 1987: 1129a–1130.
[PDF]
|
|
| Malignant melanoma in the elderly |
| R Lew and HK Koh |
|
JCO Jul 1 1987: 1129b.
[PDF]
|
|
